Illumina Inc (ILMN)
US$ 71.16-3.22%
Price Chart
Key Statistics
Market Cap
$ 11.27B
P/E Ratio
0.00
Revenue (TTM)
$ 4.37B
Volume
2.6M
52W High
$ 156.66
52W Low
$ 68.70
Dividend Yield
0.00%
Beta
1.38
Technicals
50-Day MA
87.041
200-Day MA
121.8487
52 Week High
156.66
52 Week Low
68.7
About ILMN
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Employees
8970
Headquarters
San Diego, CA
CEO
Mr. Jacob Thaysen Ph.D.
Latest News
Illumina, Tempus AI partner to drive genomic testing beyond cancer - MedTech Dive
18 hours ago • Google News
Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks - The Globe and Mail
23 hours ago • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
9.18
Percentile: 2.42
Environmental Risk Score
2.22
Percentile: 2
Social Risk Score
2.6
Percentile: 2
Governance Risk Score
5.36
Percentile: 2
Controversy Level
ESG data provided by Sustainalytics, Inc.
ILMN
Category Average
1Low Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg